Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.

Slides:



Advertisements
Similar presentations
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
Advertisements

Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Associations between Obesity and Depression by Race/Ethnicity and Education among Women: Results from the National Health and Nutrition Examination Survey,
CKD In Primary Care Dr Mohammed Javid.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 4: Cardiovascular Disease in Patients With CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
NHANES III Prevalence of Hypertension* According to BMI
Welch Center Uniting Medicine & Public Health Prevalence of Albuminuria, and its Relationship to Decreased GFR and Outcomes Josef Coresh, MD, PhD Director,
Chapter 6: Medicare Expenditures for CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
Stages of CKD – KDOQI 2002 Definitions
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Lesley Stevens MD Tufts-New England Medical Center
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
HS499 Bachelor’s Capstone Week 6 Seminar Research Analysis on Community Health.
The 2009 New Zealand Cardiovascular Guidelines Handbook What’s new?
Clinical Characteristic of Patients with Uncontrolled, Potentially Under-treated and Apparent Treatment Resistant Hypertension: NHANES 1988  Brent.
Diabetic nephropathy is a clinical syndrome.
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 4: Cardiovascular Disease in Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
Introduction 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Chapter 6: Medicare Expenditures for Persons with CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 7: Medicare Part D Prescription Drug Coverage in Patients with Chronic Kidney Disease 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
at risk) for Medicare patients aged 66 and older, by CKD status, 2013
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Saleem Jessani 1, Rasool Bux 1 and Tazeen H. Jafar 1,2. 1 Aga Khan University, Karachi, Pakistan 2 Duke-NUS Graduate Medical School, Singapore Socio-demographic.
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Sickle Cell Trait With Chronic Kidney.
Prevalence of Chronic Kidney Disease in an Urban Population
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.
Date of download: 6/25/2016 From: Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2013;159(4):
Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Chapter 2: Identification and Care of Patients With CKD
2016 Annual Data Report, Vol 1, CKD, Ch 2
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 1: CKD in the General Population
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Volume 80, Issue 1, Pages (July 2011)
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Copyright © 2012 American Medical Association. All rights reserved.
The percentage of subjects with de novo development of renal function impairment (GFR
Chapter 6: CKD among Children and Adolescents
2016 Annual Data Report, Vol 1, CKD, Ch 3
Volume 80, Issue 1, Pages (July 2011)
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Chapter 1: CKD in the General Population
Chapter 3: Morbidity and Mortality
Chapter 2: Identification and Care of Patients with CKD
GFR Estimation: From Physiology to Public Health
Volume 86, Issue 4, Pages (October 2014)
Volume 79, Issue 12, Pages (June 2011)
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
American Journal of Kidney Diseases
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study  Zhi Yu, Casey M. Rebholz, Eugenia.
Characteristics of persons with CKD without established risk factors versus those with CKD and diabetes. (A) Among participants of population-based studies.
Chapter 2: Identification and Care of Patients with CKD
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE

2Vol 1, CKD, Ch 1 vol 1 Table 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular disease, & single sample markers of CKD, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2005–2012 participants age 20 & older. Note: Cardiovascular disease designation is based on self-report of any CVD condition (see CKD Analytical Methods chapter for detail); CKD is defined as eGFR <60 or ACR ≥30. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; SR CVD, self-reported cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate;. not applicable. Percent of NHANES population No DM, SR CVD, or CKD76.5. DM only5.0. SR CVD only3.9. DM & SR CVD1.0. All CKD13.6. CKD only.8.0 DM & CKD.2.4 SR CVD & CKD.1.7 DM & SR CVD & CKD.1.5 Total

Vol 1, CKD, Ch 13 vol 1 Figure 1.1 Prevalence of CKD by stage among NHANES participants, Stages of CKD – KDOQI 2002 Definitions Stage 1: eGFR ≥ 90 ml/min/1.73m 2 and ACR ≥ 30 mg/g Stage 2: eGFR ml/min/1.73m 2 and ACR ≥ 30 mg/g Stage 3: eGFR ml/min/1.73m 2 Stage 4: eGFR ml/min/1.73m 2 Stage 5: eGFR < 15 ml/min/1.73m 2 Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2005–2012 participants age 20 & older. Whisker lines indicate 95% confidence intervals. Abbreviations: CKD, chronic kidney disease.

Vol 1, CKD, Ch 14 vol 1 Figure 1.2 eGFR distribution curves among NHANES participants, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2005–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Abbreviations: ACR, urine albumin/creatinine ratio; eGFR, estimated glomerular filtration rate.

Vol 1, CKD, Ch 15 vol 1 Figure 1.3 Urine albumin/creatinine ratio distribution of NHANES participants, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2005–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Abbreviations: ACR, urine albumin/creatinine ratio; eGFR, estimated glomerular filtration rate.

Vol 1, CKD, Ch 16 vol 1 Table 1.2 Percentage of NHANES participants within the KDIGO 2012 prognosis of CKD by GFR and albuminuria categories, Data source: National Health and Nutrition Examination Survey (NHANES), , & participants age 20 and older. Single-sample estimates of eGFR and ACR; eGFR calculated using the CKD-EPI equation. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; GFR, glomerular filtration rate; KDIGO, Kidney Disease: Improving Global Outcomes CKD Work Group.

Vol 1, CKD, Ch 17 vol 1 Table 1.3 Prevalence (%) of CKD in NHANES population within age, sex, race/ethnicity, & risk-factor categories, Data source: National Health and Nutrition Examination Survey (NHANES), , & participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Diabetes defined as HbA1c >7 percent, self-reported (SR), or currently taking glucose-lowering medications. Hypertension defined as BP ≥130/≥80 for those with diabetes or CKD, otherwise BP ≥140/≥90, or taking medication for hypertension. Values in Figure 1.12 cannot be directly compared to those in Table 1.3 due to different Survey cohorts. The table represents NHANES participants who are classified as hypertensive (measured/treated) but some of those are at target blood pressure. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; BP, blood pressure, CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate. All CKD eGFR <60 ml/min/1.73m 2 ACR ≥30 mg/g Male Female Non-Hispanic White Non-Hispanic Black/Af Am Other Diabetes Self-reported diabetes Hypertension Self-reported hypertension Self-reported cardiovascular disease Obesity (BMI 30+) All

Vol 1, CKD, Ch 18 vol 1 Figure 1.4 NHANES participants with CKD, by age & risk factor, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Diabetes defined as HbA1c >7 percent, self-reported, or currently taking glucose-lowering medications. Hypertension defined as BP ≥130/≥80 for those with diabetes or CKD, otherwise BP ≥140/≥90, or taking medication for hypertension. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; SR, self-reported.

Vol 1, CKD, Ch 19 vol 1 Figure 1.5 NHANES participants with eGFR <60 ml/min/1.73 m 2, by age & risk factor, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Diabetes defined as HbA1c >7 percent, self-reported (SR), or currently taking glucose-lowering medications. Hypertension defined as BP ≥130/≥80 for those with diabetes or CKD, otherwise BP ≥140/≥90, or taking medication for hypertension. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; SR, self-reported.

Vol 1, CKD, Ch 110 vol 1 Figure 1.6 NHANES participants with urine albumin/creatinine ratio ≥30 mg/g, by age & risk factor, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Diabetes defined as HbA1c >7 percent, self-reported (SR), or currently taking glucose-lowering medications. Hypertension defined as BP ≥130/≥80 for those with diabetes or CKD, otherwise BP ≥140/≥90, or taking medication for hypertension. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; SR, self-reported.

Vol 1, CKD, Ch 111 vol 1 Figure 1.7 Distribution of markers of CKD in NHANES participants with diabetes, hypertension, self-reported cardiovascular disease, & obesity, 2007–2012 Data Source: National Health and Nutrition Examination Survey (NHANES), 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CKD, chronic kidney disease; SR CVD, self-reported cardiovascular disease; eGFR, estimated glomerular filtration rate; HTN, hypertension.

Vol 1, CKD, Ch 112 vol 1 Figure 1.8 Adjusted odds ratios of CKD in NHANES participants by risk factor, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older; single-sample estimates of eGFR & ACR. Adj: age, sex, & race; eGFR calculated using the CKD-EPI equation. Whisker lines indicate 95% confidence intervals. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; SR, self-report.

Vol 1, CKD, Ch 113 vol 1 Figure 1.9 Adjusted odds ratios of eGFR <60 ml/min/1.73m 2 in NHANES participants by age & risk factor, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older; single-sample estimates of eGFR & ACR. Adj: age, sex, & race; eGFR calculated using the CKD-EPI equation. Whisker lines indicate 95% confidence intervals. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; SR, self-report. (a) Age category(b) CKD risk factor

Vol 1, CKD, Ch 114 vol 1 Figure 1.10 Adjusted odds ratios of urine albumin/creatinine ratio ≥30 mg/g in NHANES participants by age & risk factor, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older; single-sample estimates of eGFR & ACR. Adjusted: age, sex, & race; eGFR calculated using the CKD-EPI equation. Whisker lines indicate 95% confidence intervals. Abbreviations: ACR, urine albumin/creatinine ratio; BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HTN, hypertension; SR, self-report.

Vol 1, CKD, Ch 115 vol 1 Figure 1.11 NHANES participants with CKD aware of their kidney disease, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Abbreviations: CKD, chronic kidney disease.

Vol 1, CKD, Ch 116 vol 1 Table 1.4 Awareness, treatment, & measures of control of risk factors (% of NHANES participants), Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate. a. Hypertension defined as blood pressure ≥130/≥80 for those with CKD and diabetes; otherwise ≥140/≥90, or self- reported treatment for hypertension. b. Awareness and treatment are self-reported. Control defined as <130/<80 for those with CKD and diabetes; otherwise <140/<90. c. Total cholesterol classified according to Adult Treatment Panel III blood cholesterol guidelines (ATP III). d. Glycohemoglobin classified according to American Diabetes Association guidelines. All CKDeGFR <60 ml/min/1.73m 2 ACR ≥ Hypertension, by current hypertensive status a Non-hypertensive status Hypertensive (measured/treated) Control of hypertension among hypertensive patients b Unaware Aware, not treated Aware, treated, uncontrolled Aware, treated, controlled Total cholesterol c <200 (desirable) –239 (borderline high) (high) Uric Acid Normal High Smoking Current Former Never Control of diabetes among patients with diabetes d Glycohemoglobin <7% (controlled) Glycohemoglobin 7% or higher (uncontrolled)

Vol 1, CKD, Ch 117 vol 1 Figure 1.12 NHANES participants at target blood pressure, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Figure represents all hypertensives plus those hypertensive participants that are at target blood pressure, probably due to medication. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.

Vol 1, CKD, Ch 118 vol 1 Figure 1.13 NHANES participants within uric acid normal range, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Figure represents all hypertensives plus those hypertensive participants that are at target blood pressure, probably due to medication. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.

Vol 1, CKD, Ch 119 vol 1 Figure 1.14 NHANES participants not currently smoking, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Figure represents all hypertensives plus those hypertensive participants that are at target blood pressure, probably due to medication. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.

Vol 1, CKD, Ch 120 vol 1 Figure 1.15 Diabetic NHANES participants with glycohemoglobin <7%, Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, & 2007–2012 participants age 20 & older. Single-sample estimates of eGFR & ACR; eGFR calculated using the CKD-EPI equation. Figure represents all hypertensives plus those hypertensive participants that are at target blood pressure, probably due to medication. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.